What is the appropriate treatment for aphthous ulcers?

Treatment for Aphthous Ulcers

Topical corticosteroids are the first-line treatment for aphthous ulcers, with dexamethasone ointment or triamcinolone acetonide applied directly to lesions 3 times daily after meals providing effective pain relief and accelerated healing. 1, 2, 3

Initial Management Approach

First-Line Topical Therapy

• Apply topical corticosteroids (such as dexamethasone ointment or triamcinolone acetonide) directly to ulcers 3 times daily after meals for 5 days 1, 3
• Dexamethasone ointment significantly reduces ulcer size (7.2 mm² reduction vs 4.3 mm² with placebo) and pain scores, with an 83% healing rate compared to 55% with placebo 3
• Topical corticosteroids remain undetectable in serum (<0.502 ng/mL), confirming safety for oral mucosal application 3

Adjunctive Topical Measures

• Topical anesthetics (lidocaine gel) for immediate pain relief 1, 4
• Chlorhexidine rinses for oral hygiene maintenance 1
• Sucralfate suspension has demonstrated efficacy in randomized controlled trials for both oral and genital ulcers 1

Alternative First-Line Options

• Hyaluronic acid shows favorable short-term efficacy with excellent safety profile 5
• Low-level laser therapy consistently reduces pain and shortens healing time across multiple trials 6, 5
• CO₂ laser treatment is superior to conventional therapy for pain management 6

Management of Recurrent Aphthous Stomatitis (RAS)

When ulcers recur ≥4 times per year, escalate treatment:

Second-Line Systemic Therapy

• Colchicine is the preferred systemic agent when combined with topical treatments for most cases of RAS 1, 4
• Particularly effective when erythema nodosum is the dominant lesion in Behçet's disease 1

Resistant or Severe Cases

For ulcers unresponsive to topical corticosteroids and colchicine:

• Azathioprine 2.5 mg/kg/day for prevention of mucocutaneous lesions 1
• Thalidomide is the most effective treatment for RAS but reserved for refractory cases due to serious adverse effects including teratogenicity and permanent peripheral neuropathy 1, 4, 5
• Interferon-alpha produces significant improvement in mucocutaneous lesions based on RCT evidence 1
• TNF-α antagonists (etanercept) for most resistant cases, though cost and side effects limit use 1

Systemic Disease Evaluation

Before escalating therapy, investigate underlying conditions:

• Screen for celiac disease, inflammatory bowel disease (Crohn's disease, ulcerative colitis) 4
• Check nutritional deficiencies: iron, folate, vitamin B12 4
• Evaluate immune status: HIV, neutropenia 4
• Consider Behçet's disease if bipolar aphthosis (oral and genital) present 1, 4

Treatment Algorithm by Severity

Minor Aphthous Ulcers (Most Common)

• Start with topical corticosteroids 3 times daily for 5 days 3
• Add topical anesthetics for pain control 1
• If recurrence >4 times/year, add colchicine systemically 4

Major Aphthous Ulcers (Refractory, >10mm)

• Topical corticosteroids plus systemic corticosteroids (prednisone) 7
• If persistent >10 months despite topical therapy, implement multidisciplinary approach with systemic immunomodulators 8
• Consider azathioprine or thalidomide for long-term disease-free state 8

Herpetiform Aphthous Ulcers

• Topical corticosteroids remain first-line 2
• Doxycycline as topical antibiotic alternative 7

Important Caveats

• Do not use topical antiseptic or antimicrobial dressings for wound healing purposes, as strong evidence shows no benefit 9
• Avoid herbal remedies without established efficacy 9
• Biopsy any solitary chronic ulcer persisting beyond expected healing time to rule out squamous cell carcinoma 4
• Genital aphthous ulcers in peri-menarchal patients are typically self-limited and managed with supportive care 10